HOME >> BIOLOGY >> NEWS
Johnson & Johnson announces call for nominations

New Brunswick, New Jersey February 15, 2007 Johnson & Johnson today announced that it will accept nominations for The 2008 Dr. Paul Janssen Award for Biomedical Research beginning on June 1, 2007. At that time, nominations will be accepted on-line via the Award website at http://www.pauljanssenaward.com and the winner will be announced in September 2008.

The Dr. Paul Janssen Award for Biomedical Research was established by Johnson & Johnson in 2004 to honor Dr. Paul Janssen, founder of Janssen Pharmaceutica. Dr. Janssen, who was known to his colleagues as Dr. Paul, was one of the most innovative, creative, and productive scientists of the 20th century. The Award is designed to acknowledge a scientist from anywhere in the world whose work has the potential to make a significant transformational contribution toward the improvement of human health. Given every two years, the Award includes a $100,000 cash prize and recipients are chosen by an independent Selection Committee composed of world-leading scientists and clinicians Solomon Snyder, M.D., D.Sc., D.Phil. (Hon. Causa), professor and director of the Department of Neuroscience at Johns Hopkins School of Medicine will chair the Selection Committee for the 2008 Award.

I am very honored to chair the 2008 Dr. Paul Janssen Award Selection Committee, said Dr. Snyder. I expect there will be many excellent scientists nominated for this award and selecting a winner will be a challenging process. However, we are looking forward to finding the scientist whose work and research has the potential to help millions of people while epitomizing the passion, leadership and innovation that defined Dr. Janssen.

Craig C. Mello, Ph. D., a professor of Molecular Medicine at the University of Massachusetts Medical School, Worcester, MA, and an investigator at the Howard Hughes Medical Institute, was named the inaugural recipient of the Award in September 20
'"/>


16-Feb-2007


Page: 1 2

Related biology news :

1. Gladstones Deepak Srivastava receives E. Mead Johnson Award for achievement in pediatrics
2. VIB and Johnson & Johnson set up a new fund
3. Johnson & Johnson names selection committee for Dr. Paul Janssen Award for Biomedical Research
4. HSPHs Walter Willett wins Bristol-Myers Squibb/Mead Johnson Freedom to Discover Award
5. Conservation International and SC Johnson partner again to offset carbon impacts
6. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
7. ESA announces 2007 award recipients
8. President Bush announces 2005 and 2006 Laureates of National Medals of Science and Technology
9. Conservation Leadership Program announces 2007 awardees
10. ACMG Foundation announces 2007-2008 Luminex/ACMGF award recipient
11. Revolutionary global environment fund announces $50M expansion

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Johnson Johnson announces call for nominations

(Date:4/23/2014)... term for novels and films which focus on the consequences ... how these fictions serve as a mental laboratory that allows ... imagine other living conditions. , "Global warming is much ... is also a cultural phenomenon in which meaning is being ... see. And there are so many of them now that ...
(Date:4/23/2014)... biomedical engineer at the University of Houston (UH) is ... transfusions safer. His work is supported by a $1.8 ... , Blood transfusions save millions of lives every ... Without them, for instance, routine surgeries would become life ... strong evidence that transfusions of red blood cells stored ...
(Date:4/22/2014)... to behave at the dinner tablecut up their food and ... Eating Behaviors , found that when 6-10 year old children ... such as drumsticks, whole apples, or corn on the cob ... cut. "They were twice as likely to disobey adults ... Professor and Director of the Cornell Food and Brand Lab. ...
Breaking Biology News(10 mins):Fiction prepares us for a world changed by global warming 2Fiction prepares us for a world changed by global warming 3UH biomedical engineer works to make blood transfusions safer 2UH biomedical engineer works to make blood transfusions safer 3Biting vs. chewing 2
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
Breaking Biology Technology:World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
Cached News: